Evidence mapPaperPMID 42553399Full record

ReviewFrontiers in microbiology2026

The role of the gut microbiota-uric acid metabolism axis in high-altitude hyperuricemia: dysregulation mechanisms, pathway associations and therapeutic perspectives.

Chuankai Shi, Lemeng Li, Wenping Ge, Yuan Gao, Yiyang Li, Wuhui Li, Jiangwei Liu

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chuankai Shi *Department of Graduate School, Xinjiang Medical University, Ürümqi, China.
Lemeng Li *The First Clinical Medical College, Xinjiang Medical University, Ürümqi, China.
Wenping Ge *Key Laboratory of Special Environmental Medicine of Xinjiang, General Hospital of Xinjiang Military Command, Ürümqi, China.
Yuan GaoThe First Clinical Medical College, Xinjiang Medical University, Ürümqi, China.
Yiyang LiThe First Clinical Medical College, Xinjiang Medical University, Ürümqi, China.
Wuhui LiKey Laboratory of Special Environmental Medicine of Xinjiang, General Hospital of Xinjiang Military Command, Ürümqi, China.
Jiangwei LiuKey Laboratory of Special Environmental Medicine of Xinjiang, General Hospital of Xinjiang Military Command, Ürümqi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-altitude areas (≥2500 m) are characterized by low oxygen concentrations, which leads more people affected by high uronic acid in the blood. This review systematically investigates the "gut microbiota-uric acid metabolism axis" as a potential target for inhibiting Hyperuricemia (HUA). This review introduces the four functions of the axis: direct reduction of uric acid, intestinal excretion, regulation of uricase expression, and the intestinal-renal axis signal; then investigates how hypoxia alters all of these paths. In addition, this review illustrates how this axis is related to the classical metabolic pathway of purine synthesis, renal excretion, lactate metabolism, inflammatory-oxidative stress and genetic susceptibility. Adaptation difference: Native highlanders and migrants show different degrees of adjustment to life in the mountains, and migrants are relatively more prone to axis dysfunction. Finally, this review introduces targeted intervention strategies, such as probiotics, prebiotics, fecal microbiota transplantation, and their combination with uric acid-lowering or anti-inflammatory drugs, and put forward a population-stratified precision intervention framework. Overall, this paper provides a theoretical foundation and novel direction for understanding and preventing plateau HUA.

Indexed as

gut florahyperuricemiahypoxiaintervention strategiesuric acid metabolism

Identifiers

PMID42553399
PMCPMC13434285

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.